Brijesh Srivastava1, Graeme J M Alexander. Show Affiliations » 1. Department of Hepatology, Addenbrooke's Hospital, Cambridge, UK.
Abstract
Entities: Disease
Mesh： See more » Bilirubin/bloodChronic DiseaseEvidence-Based PracticeFluid Therapy/methodsHemodynamicsHepatorenal Syndrome/classificationHepatorenal Syndrome/etiologyHepatorenal Syndrome/metabolismHepatorenal Syndrome/physiopathologyHepatorenal Syndrome/therapyHumansKidney/blood supplyLiver/blood supplyLiver Cirrhosis/complicationsLiver Cirrhosis/metabolismLiver Cirrhosis/physiopathologyLiver TransplantationLypressin/administration & dosageLypressin/adverse effectsLypressin/analogs & derivativesMonitoring, PhysiologicPatient SelectionPortasystemic Shunt, SurgicalRegional Blood Flow/drug effectsRenal Insufficiency/diagnosisRenal Insufficiency/etiologyRenal Insufficiency/metabolismRenal Insufficiency/physiopathologyRenal Insufficiency/therapySerum Albumin/analysisSerum Albumin/metabolismSeverity of Illness IndexTerlipressinVasoconstrictor Agents/administration & dosageVasoconstrictor Agents/adverse effects
Substances： See more » Serum AlbuminVasoconstrictor AgentsLypressinTerlipressinBilirubin
Year: 2011 PMID： 22041830 DOI： 10.12968/hmed.2011.72.9.497
Source DB: PubMed Journal: Br J Hosp Med (Lond) ISSN： 1750-8460 Impact factor: 0.825